Key Highlights
- Rocket One (RKTO) secured entry into SpaceXAI’s API program, unlocking access to advanced multimodal AI technologies
- Shares climbed approximately 24% following the announcement, reaching around $0.80 with a $15.35 million market capitalization
- The API integration provides capabilities spanning coding, reasoning, text processing, image analysis, video interpretation, and voice recognition
- The company intends to deploy these AI models within its defense software, space technology, and AI infrastructure projects
- Rocket One maintains exclusive licensing for nanomagnetic and spintronic semiconductor innovations
Rocket One (RKTO) revealed Wednesday that SpaceXAI has approved its entry into the company’s API program, providing the defense-focused technology firm with direct access to SpaceXAI’s cutting-edge multimodal artificial intelligence systems. Shares responded with a roughly 24% surge, reaching approximately $0.80 per share.
With a modest market capitalization of $15.35 million, the firm now possesses access to SpaceXAI’s comprehensive suite of AI models spanning multiple domains: coding assistance, logical reasoning, text generation, image processing, video analysis, and voice interaction technologies.
According to company statements, Rocket One intends to evaluate these advanced capabilities across multiple operational areas, including core AI infrastructure development, autonomous military software systems, and space-based computing applications. The scope appears ambitious relative to the organization’s current scale.
CEO Robb Knie emphasized that securing access to premier foundation models represents a critical milestone as the organization constructs what it characterizes as an AI-centric platform tailored for defense and aerospace markets.
The SpaceXAI partnership will complement Rocket One’s current technological framework, which features exclusive licensing agreements for nanomagnetic and spintronic semiconductor innovations.
The organization is actively developing radiation-resistant AI chip technology specifically engineered to operate reliably in challenging environments including low-Earth orbit missions, deep-space applications, and military deployments where conventional semiconductor components typically fail.
This proprietary nanomagnetic matrix multiplier design functions as a hardware acceleration solution for machine learning tasks. However, the technology has not yet been manufactured as a complete integrated circuit and remains untested in actual space conditions.
Latest Developments at Rocket One
The SpaceXAI partnership announcement follows several months of significant corporate activity. In June, Rocket One disclosed approximately $8.4 million in liquid assets and cash equivalents, funds generated through an at-the-market equity offering program.
The organization also unveiled Swarm Stage AI, an autonomous drone swarm defense system designed for military agencies, government entities, and security contractors. The platform incorporates technology obtained through the acquisition of SkyStage, a commercial drone-swarm technology company.
Regarding leadership additions, Rocket One appointed retired Colonel Robert “Shane” Kimbrough — a veteran NASA astronaut — to its Space Advisory Board.
Additionally, the company recently satisfied Nasdaq’s minimum bid price requirements after its shares maintained a valuation above $1.00 for ten consecutive trading sessions.
Wall Street Perspective
At least one analyst has established a $5.00 price objective for RKTO shares. Projections suggest potential earnings of $8.21 per share by fiscal year 2026, though this forecast appears notably optimistic considering the company’s present share price and market valuation.
InvestingPro’s analysis indicates the stock may be trading below its intrinsic value according to their Fair Value methodology. Nevertheless, shares remain down 44% year-over-year despite Wednesday’s significant rally.
The company’s biotechnology research portfolio — encompassing programs designated HT-001, HT-KIT, HT-ALZ, and a GDNF-focused metabolic initiative — operates through a fully owned subsidiary entity, functioning independently from primary defense and aerospace business lines.
As of Wednesday morning trading, RKTO shares were changing hands at $1.0001, representing a $0.1977 increase for the session.





